[1] Drossman, D.A. and W.L. Hasler, Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology, 2016. 150(6): p. 1257-61.
[2] Canavan, C., J. West, and T. Card, The epidemiology of irritable bowel syndrome. Clin Epidemiol, 2014. 6: p. 71-80.
[3] Liu, J. and X. Hou, A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis, and pathophysiology in China. J Gastroenterol Hepatol, 2011. 26 Suppl 3: p. 88-93.
[4] Endo, Y., T. Shoji, and S. Fukudo, Epidemiology of irritable bowel syndrome. Ann Gastroenterol, 2015. 28(2): p. 158-159.
[5] Gwee, K.A., U.C. Ghoshal, and M. Chen, Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management. J Gastroenterol Hepatol, 2018. 33(1): p. 99-110.
[6] Azpiroz, F. and J.R. Malagelada, The pathogenesis of bloating and visible distension in irritable bowel syndrome. Gastroenterol Clin North Am, 2005. 34(2): p. 257-69.
[7] Pei, L.X., et al., Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial. Trials, 2018. 19(1): p. 529.
[8] Zheng, H., et al., Comparison between the Effects of Acupuncture Relative to Other Controls on Irritable Bowel Syndrome: A Meta-Analysis. Pain Res Manag, 2019. 2019: p. 2871505.
[9] study group of functional gastrointestinal disorders, s.g.o.g.m., Chinese society of gastroenterology,Chinese medical association., Chinese expert consensus of irritable bowel syndrome in 2020. Chin J Dig, 2020: p. 2020,40(12):803-818.
[10] Aziz, I., et al., How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. Am J Gastroenterol, 2018. 113(7): p. 1017-1025.
[11] Standardization Administration of China: The SAC Register (2006). Accessed 18 Sept 2006.
[12] Betz, C., K. Mannsdorfer, and S.C. Bischoff, [Validation of the IBS-SSS]. Z Gastroenterol, 2013. 51(10): p. 1171-6.
[13] Blake, M.R., J.M. Raker, and K. Whelan, Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhea-predominant irritable bowel syndrome. Aliment Pharmacol Ther, 2016. 44(7): p. 693-703.
[14] Thandi, G., N.T. Fear, and T. Chalder, A comparison of the Work and Social Adjustment Scale (WSAS) across different patient populations using Rasch analysis and exploratory factor analysis. J Psychosom Res, 2017. 92: p. 45-48.
[15] Andrae, D.A., et al., Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients. Health Qual Life Outcomes, 2013. 11: p. 208.
[16] Dunstan, D.A. and N. Scott, Norms for Zung's Self-rating Anxiety Scale. BMC Psychiatry, 2020. 20(1): p. 90.
[17] Dunstan, D.A. and N. Scott, Clarification of the cut-off score for Zung's self-rating depression scale. BMC Psychiatry, 2019. 19(1): p. 177.
[18] Hu, Z., et al., The level, and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis. BMC Gastroenterol, 2021. 21(1): p. 23.
[19] Li, Y.L., et al., Acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome: A protocol for meta-analysis. Medicine (Baltimore), 2020. 99(48): p. e23457.
[20] Dai, Y.K., et al., Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults. World J Gastroenterol, 2020. 26(41): p. 6488-6509.
[21] Guo, J., et al., Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis. Neural Plast, 2020. 2020: p. 8892184.
[22] Southwell, B.R., Electro-Neuromodulation for Colonic Disorders-Review of Meta-Analyses, Systematic Reviews, and RCTs. Neuromodulation, 2020. 23(8): p. 1061-1081.
[23] Yin S, C.Y., Lei D, et al., Cerebral mechanism of puncturing at He-Mu point combination for functional dyspepsia: study protocol for a randomized controlled parallel trial. Neural Regen Res: p. 12(5):831-840.
[24] Gendi, R. and N. Jahan, Pharmacological and Non-pharmacological Treatments of Irritable Bowel Syndrome and Their Impact on the Quality of Life: A Literature Review. Cureus, 2020. 12(7): p. e9324.
[25] Zheng, H., et al., Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: A randomized controlled trial. Medicine (Baltimore), 2016. 95(24): p. e3884.
[26] Genc, F. and M. Tan, The effect of acupressure application on chemotherapy-induced nausea, vomiting, and anxiety in patients with breast cancer. Palliat Support Care, 2015. 13(2): p. 275-84.